Merck | MRK - Assets


Merck reported EUR53.07B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Adidas EUR 20.45B 192M Mar/2026
Adyen EUR 12.26B 1.68B Dec/2025
Akzo Nobel EUR 15.49B 1.53B Mar/2026
Alcon AG USD 31.62B 64M Mar/2026
Amadeus IT EUR 11.43B 44.1M Mar/2026
Amarin USD 645.76M 25.01M Mar/2026
AstraZeneca USD 114.02B 59M Mar/2026
BASF EUR 76.17B 267M Dec/2025
Bayer EUR 107.94B 3.4B Mar/2026
Beiersdorf EUR 12.76B 166M Dec/2025
Covestro EUR 13.47B 245M Dec/2025
Danone EUR 45.07B 1.32B Dec/2025
Fresenius EUR 41.4B 1.07B Dec/2025
Fresenius Medical Care EUR 31.47B 465.26M Mar/2026
Genmab DKK 12.87B 5.85B Dec/2025
Givaudan CHF 11.86B 587M Dec/2025
GlaxoSmithKline GBP 62.87B 1.75B Mar/2026
GRIFOLS EUR 20.08B 366M Mar/2026
Henkel EUR 32.53B 258M Dec/2025
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Infineon EUR 31.72B 978M Mar/2026
Lakefront Biotherapeutics EUR 3.37B 34.09M Mar/2026
Linde USD 86.32B 502M Mar/2026
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 53.07B 1.54B Mar/2026
Novartis USD 118.53B 7.58B Mar/2026
Philips EUR 27.27B 322M Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 128.02B 1.22B Mar/2026
UCB EUR 18.16B 971M Dec/2025